Search for Johnson & Johnson Co Inc and
    1. May 28, 2015

      Sponsors step up pressure on Fifa over corruption probe

      Companies close to Fifa have stepped up pressure on football’s governing body, after US and Swiss authorities combined to...

    2. May 22, 2015

      Reckitt faces regulatory friction in UK over K-Y acquisition

      The coupling of Durex condoms with K-Y lubricant under Reckitt Benckiser is facing regulatory friction in the UK. Concerns...

    Special Reports

    1. Combating Cancer

      A wave of drugs that harnesses the body’s immune system is fuelling optimism that scie...
    2. Combating Hepatitis C

      Treatment for the virus is in the midst of its biggest advance for at least a decade a...
    Search more Special Reports on this topic.

    1. April 26, 2015

      No end in sight to wave of pharma dealmaking

      Since the start of last year, pharmaceuticals companies have agreed $462bn of mergers and acquisitions — greater than the...

    2. April 26, 2015

      Apple set to be latest to suffer dollar impact

      A surge in the US dollar has already wiped more than $20bn from first quarter sales at the largest US companies, a sum...

    3. April 14, 2015

      J&J cuts guidance as strong dollar hits sales

      Johnson & Johnson has cut its full-year earnings guidance as the strengthening of the US dollar caused a dip in...

    4. April 14, 2015

      Johnson & Johnson: playing patience

      Wouldn’t this just be the perfect time for a nice, big, value-destroying acquisition? Johnson & Johnson shares have been...

    5. April 13, 2015

      IBM strikes digital health deal with Apple, Medtronic and J&J

      IBM has struck partnerships with Apple and the world’s biggest makers of medical devices, to put health data from Apple...

    6. April 7, 2015

      Big pharma turns to small biotechs for edge in cancer treatment

      Partnerships between big pharma and small biotech companies have highlighted the scramble for assets in a new category of...

    7. April 1, 2015

      Europe seeks to emulate US biotech investment boom

      A Belgian medical diagnostics company backed by Johnson & Johnson will announce plans for an initial public offering on...

    8. March 27, 2015

      Dr Google assists in robotic surgery

      Dr Google will see you shortly. The Silicon Valley company has teamed up with Johnson & Johnson to develop a new generation...

    9. March 23, 2015

      Pharmacyclics chief to receive $3.6bn from takeover

      Executives and directors at Pharmacyclics are set to share almost $4bn from the sale of the company for $21bn to AbbVie,...

    10. March 19, 2015

      The charity that matches surplus medicine with acute need

      Pharmaceuticals executives might not seem the most likely recipients of hospitality from HRH the Prince of Wales. The heir...

    11. March 17, 2015

      Dementia research boosted by $100m venture capital fund

      Research into dementia is to be boosted by a $100m venture capital fund backed by the UK government and several of the...

    12. March 6, 2015

      Going the extra mile to win a $21bn deal

      The Pharmacyclics executives could hardly believe the turn of events. As they gathered on Wednesday at the drugmaker’s law...

    13. March 6, 2015

      US regulators approve first biosimilar drug

      US regulators have approved the first of a new class of drugs called biosimilars, which promise to shave billions of dollars...

    14. March 5, 2015

      AbbVie wins three-way fight over Pharmacyclics

      A late-night bidding war for a Californian biotech company has taken the value of healthcare deals in the past 15 months to...

    15. March 5, 2015

      AbbVie joins the pharma chain reaction

      As executives from Johnson & Johnson huddled with their advisers, including Goldman Sachs, late on Wednesday, there was...

    16. March 5, 2015

      AbbVie/Pharmacyclics: pay to play

      At this price, everything has to go perfectly. AbbVie has nosed out Johnson & Johnson, among other bidders, for...

    17. March 5, 2015

      Q&A: why AbbVie had to strike $21bn Pharmacyclics deal

      AbbVie has taken another spin on the drug industry’s mergers and acquisitions merry-go-round with a $21bn swoop for...

    18. FT Alphaville

      March 5, 2015

      FirstFT (the new 6am Cut)

      You can sign up to receive the email here. China’s ersatz parliament, the National People’s Congress, kicked off today. The...

    19. March 4, 2015

      AbbVie in $21bn swoop on Pharmacyclics

      AbbVie has agreed to acquire Pharmacyclics for $21bn in what people involved in the negotiations described as one of the...

    20. March 2, 2015

      GSK-Novartis deal ‘a model’ for industry

      A $2bn disposal by Johnson & Johnson and the completion of a $20bn asset swap between GlaxoSmithKline and Novartis on Monday...

    21. February 25, 2015

      Pharmacyclics considers $19bn sale

      Pharmacyclics is considering a sale that could value the US cancer drugs maker at about $19bn, according to people familiar...

    22. January 20, 2015

      Delta takes flight as earnings soar ahead of forecasts

      Delta Air Lines was one of the best performing stocks on the US benchmark on Tuesday, as the airline operator beat...

    23. January 16, 2015

      J&J receives €100m EU injection for Ebola vaccine development

      Johnson & Johnson is to receive more than €100m from the EU to accelerate development of its experimental Ebola vaccine as...

    24. January 12, 2015

      Fresh round of M&A sweeps pharma sector

      Another round of mergers and acquisitions is sweeping the pharmaceuticals sector, in a sign that last year’s boom in...

    25. January 9, 2015

      Two Ebola vaccines given go-ahead for trials in west Africa

      Two vaccines for Ebola have been given the go-ahead for frontline trials in west Africa as the World Health Organisation...

    26. January 5, 2015

      Caterpillar falls on downgrade due to oil and gas exposure

      Caterpillar was among the worst-performing stocks on the US benchmark on Monday, after JPMorgan analysts downgraded the...

    27. December 10, 2014

      Digital future signals more active role for the patient

      Healthcare has been slower than other industries to feel the full force of digital technology. Whereas everyday activities...

    28. November 17, 2014

      GlaxoSmithKline leads Access to Medicine Index

      GlaxoSmithKline is leading the pharmaceuticals industry in efforts to widen global access to medicines, according to a...

    29. November 7, 2014

      US earnings boost masks revenue fears

      Beating earnings expectations has long been the game played by companies and Wall Street. And the latest results season has...

    30. November 5, 2014

      Sweeteners, incentives – and abundant water supplies – help draw multinationals to Wallonia

      Wallonia is usually promoted on the basis of its location, its easy access to European and global communication networks and...

    31. November 4, 2014

      AstraZeneca strikes deals on cancer drugs

      AstraZeneca struck two deals on Tuesday aimed at strengthening its position in cancer drugs, as the UK pharmaceuticals group...

    32. October 23, 2014

      Industry response to Ebola quickens

      Pharmaceutical executives and international donors were thrashing out details of a push to accelerate development of...

    33. October 22, 2014

      GSK expects first doses of Ebola vaccine ready by year end

      GlaxoSmithKline said it expected to have the first doses of its experimental Ebola vaccine ready by the end of this year, as...

    34. October 16, 2014

      Pharma giants face developing market ambitions

      As the pharmaceuticals industry careered towards the edge of its notorious patent cliff over the past decade, there was one...

    35. October 14, 2014

      J&J slips despite upbeat forecasts

      US pharmaceutical companies are set to report earnings in coming weeks and Johnson & Johnson has kicked things off by...

    36. October 9, 2014

      War waged on scourge of the lesser known diseases

      It is one of Africa’s most feared diseases with symptoms including fever, swelling of internal organs and skin lesions. If...

    37. October 3, 2014

      Guinter Kahn, dermatologist, 1934-2014

      Scientists have been seeking a cure for baldness since the dawn of modern medicine. Hippocrates experimented with a...

    38. September 26, 2014

      Drug development: Big pharma back in the game it made

      Big pharma is back. That, at least, is the impression created by a wave of new cancer drugs rapidly approaching market....

    Search for Johnson & Johnson Co Inc and